
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 882 | 888 | 882 | 599 | 761 | - |
Fund Return | -11.75% | -11.18% | -11.75% | -15.71% | -5.32% | - |
Place in category | 166 | 160 | 166 | 140 | 102 | - |
% in Category | 79 | 82 | 79 | 83 | 81 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPI Global Income Fund A mth USD he | 17.27B | 1.98 | 2.67 | 3.89 | ||
JPI Global Income Fund C acc USD he | 17.27B | 2.03 | 3.37 | 4.60 | ||
JPI Global Income Fund C dist USD h | 17.27B | 2.03 | 3.36 | 4.59 | ||
JPI Global Income Fund C mth USD he | 17.27B | 2.03 | 3.37 | 4.59 | ||
JPI Global Income Fund D acc USD he | 17.27B | 1.95 | 2.33 | 3.55 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Biotech Z USD | 1.25B | -0.94 | 7.69 | 3.16 | ||
Franklin Biotech Discovery Nacc | 95.4M | 1.89 | 0.99 | 1.49 | ||
Equities L Biotechnology Class R US | 1.3B | 3.48 | 8.71 | 5.94 | ||
Equities L Biotechnology Class I US | 1.3B | 2.92 | 2.58 | 5.59 | ||
Candriam Equities Biotech C USD Cap | 1.3B | 3.56 | 7.84 | 5.10 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Gilead | US3755581036 | 3.55 | 114.43 | -2.37% | |
Vericel Corp Ord | US92346J1088 | 3.55 | 47.81 | -2.13% | |
Bio-Techne | US09073M1045 | 3.38 | 58.47 | -7.04% | |
Novartis | CH0012005267 | 3.32 | 95.70 | -5.60% | |
PTC Therapeutics | US69366J2006 | 3.31 | 52.59 | +0.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review